首頁 > 市場調查報告書 > 醫療設備

體外診斷生技設備

市場調查報告書

商品編碼

1762319

性傳染病分子診斷市場，規模，佔有率，趨勢，產業分析報告:各產品，各用途，各技術，各地區，2025年～2034年的市場預測

Molecular Diagnostics For Sexually Transmitted Diseases Market Size, Share, Trends, & Industry Analysis Report By Product (Instruments & Services, Consumables, and Software), By Application, By Technology, By Region - Market Forecast, 2025-2034

出版日期: 2025年06月01日 | 出版商:

Polaris Market Research | 英文 123 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

根據 Polaris Market Research 的最新研究，全球性傳染病分子診斷市場規模預計到 2034 年將達到 78.5 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

性傳染病 (STD) 分子診斷採用先進的實驗室技術，用於識別導致這些感染的微生物的遺傳物質，例如 DNA 或 RNA。與抗體或培養液檢測等傳統方法不同，分子檢測可以直接辨識病原體本身。這使得檢測高度準確且靈敏，通常可以在感染早期或症狀尚未出現時進行診斷。

隨著全球性傳染病的盛行率不斷上升，性傳染病分子診斷市場正在經歷顯著增長，這需要更有效、更快速的診斷解決方案來應對公共衛生課題。此外，分子檢測技術的不斷進步，例如能夠同時檢測多種病原體的多重檢測方法的開發，正在提高檢測效率和可及性。醫療保健專業人員和公眾對早期準確性傳播疾病診斷重要性的認識不斷提高，也促進了這些先進診斷方法的普及。

性傳染病分子診斷市場報告重點

按產品劃分，包括試劑和試劑盒在內的耗材佔據了最大的佔有率，因為它們在任何性傳染病分子檢測中都發揮著至關重要的作用。

按應用劃分，CT/NG 檢測領域在 2024 年佔據主導地位。

從技術角度來看，由於中心化實驗室完善的基礎設施，實驗室檢測領域在 2024 年佔據最大佔有率。

按地區劃分，北美在 2024 年佔據性傳染病分子診斷市場的主導銷售佔有率。預計亞太地區將成為預測期內成長最快的地區。

市場主要參與者包括雅培實驗室、羅氏診斷公司（羅氏診斷）、生物梅里埃公司、凱傑公司、豪洛捷公司、碧迪公司、西門子醫療公司、DiaSorin公司、賽默飛世爾科技公司、QuidelOrtho公司和Seegene公司。

主要調查結果
簡介
- 性傳染病分子診斷市場評估:各地區，2020～2034年
北美
- 北美:各產品，2020～2034年
- 北美:各用途，2020～2034年
- 北美:各技術，2020～2034年
- 美國
- 加拿大
歐洲
- 歐洲:各產品，2020～2034年
- 歐洲:各用途，2020～2034年
- 歐洲:各技術，2020～2034年
- 英國
- 法國
- 德國
- 義大利
- 西班牙
- 荷蘭
- 俄羅斯
- 其他歐洲
亞太地區
- 亞太地區:各產品，2020～2034年
- 亞太地區:各用途，2020～2034年
- 亞太地區:各技術，2020～2034年
- 中國
- 印度
- 馬來西亞
- 日本
- 印尼
- 韓國
- 澳洲
- 其他亞太地區
中東·非洲
- 中東·非洲:各產品，2020～2034年
- 中東·非洲:各用途，2020～2034年
- 中東·非洲:各技術，2020～2034年
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 南非
- 其他中東和非洲
南美
- 南美:各產品，2020～2034年
- 南美:各用途，2020～2034年
- 南美:各技術，2020～2034年
- 墨西哥
- 巴西
- 阿根廷
- 其他南美國家

第9章競爭情形

擴大和收購的分析
- 擴大
- 收購
聯盟/合作/協定/公開

第10章企業簡介

Abbott Laboratories
Becton, Dickinson and Company(BD)
bioMerieux SA
DiaSorin S.p. A.
F. Hoffmann-La Roche AG(Roche Diagnostics)
Hologic Inc.
QIAGEN N.V.
QuidelOrtho Corporation
Seegene Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: PM5807

The global molecular diagnostics for sexually transmitted diseases market size is expected to reach USD 7.85 billion by 2034, according to a new study by Polaris Market Research. The report "Molecular Diagnostics for Sexually Transmitted Diseases Market Size, Share, Trends, & Industry Analysis Report By Product (Instruments & Services, Consumables, and Software), By Application, By Technology, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Molecular diagnostics for sexually transmitted diseases (STDs) involves advanced laboratory techniques that pinpoint the genetic material, such as DNA or RNA, of the microorganisms causing these infections. Unlike older methods that might look for antibodies or grown cultures, molecular tests directly identify the pathogen itself. This allows for highly accurate and sensitive detection, often enabling diagnosis even in the early stages of an infection or when symptoms are not yet present, which is crucial for timely treatment and preventing further spread.

The market for molecular diagnostics for STDs is experiencing significant growth due to the rising global incidence of STDs, which necessitates more effective and rapid diagnostic solutions to manage public health challenges. Additionally, ongoing technological advancements in molecular testing, including the development of multiplex assays that can detect multiple pathogens simultaneously, are enhancing testing efficiency and accessibility. The increasing awareness among healthcare professionals and the general public about the importance of early and accurate STD diagnosis also contributes to the expanding adoption of these advanced diagnostic methods.

Molecular Diagnostics for Sexually Transmitted Diseases Market Report Highlights:

By product, the consumables segment, encompassing reagents and kits, holds the largest share due to its essential role in every molecular STD test.

Based on application, the CT/NG testing segment dominated in 2024 as these are among the most prevalent STDs worldwide.

In terms of technology, the laboratory testing segment held the largest share in 2024, supported by the established infrastructure of centralized labs.

By region, North America dominated the molecular diagnostics for sexually transmitted diseases market revenue share in 2024. Asia Pacific is projected to witness the fastest growth during the forecast period.

A few key players in the market include Abbott Laboratories; F. Hoffmann-La Roche AG (Roche Diagnostics); bioMerieux SA; QIAGEN N.V.; Hologic Inc.; Becton, Dickinson and Company (BD); Siemens Healthineers AG; DiaSorin S.p.A.; Thermo Fisher Scientific Inc.; QuidelOrtho Corporation; and Seegene Inc.

Polaris Market Research has segmented the molecular diagnostics for sexually transmitted diseases market report on the basis of product, application, technology, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Instruments & Services

Consumables

Software

By Application Outlook (Revenue - USD Billion, 2020-2034)

CT/NG Testing

Syphilis Testing

Gonorrhea Testing

HSV Testing

HPV Testing

HIV Testing

Trichomonas

Ureaplasma + Mycoplasma

Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

Laboratory Testing

Commercial/Private Labs

Public Health Labs

PoC testing

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Molecular Diagnostics For Sexually Transmitted Diseases Market Insights

4.1. Molecular Diagnostics For Sexually Transmitted Diseases Market - Market Snapshot
4.2. Molecular Diagnostics For Sexually Transmitted Diseases Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Incidence of Sexually Transmitted Diseases
  - 4.2.1.2. Technological Advancements in Diagnostic Tools
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Diagnostic Tests and Equipment
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Molecular Diagnostics For Sexually Transmitted Diseases Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
5.3. Instruments & Services
- 5.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Instruments & Services, by Region, 2020-2034 (USD Billion)
5.4. Consumables
- 5.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Consumables, by Region, 2020-2034 (USD Billion)
5.5. Software
- 5.5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Software, by Region, 2020-2034 (USD Billion)

6. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
6.3. CT/NG testing
- 6.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by CT/NG testing, by Region, 2020-2034 (USD Billion)
6.4. Syphilis testing
- 6.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Syphilis testing, by Region, 2020-2034 (USD Billion)
6.5. Gonorrhea testing
- 6.5.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Gonorrhea testing, by Region, 2020-2034 (USD Billion)
6.6. HSV testing
- 6.6.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HSV testing, by Region, 2020-2034 (USD Billion)
6.7. HPV testing
- 6.7.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HPV testing, by Region, 2020-2034 (USD Billion)
6.8. HIV testing
- 6.8.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by HIV testing, by Region, 2020-2034 (USD Billion)
6.9. Trichomonas
- 6.9.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Trichomonas, by Region, 2020-2034 (USD Billion)
6.10. Ureaplasma + Mycoplasma
- 6.10.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Ureaplasma + Mycoplasma, by Region, 2020-2034 (USD Billion)
6.11. Others
- 6.11.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
7.3. Laboratory Testing
- 7.3.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Laboratory Testing, by Region, 2020-2034 (USD Billion)
- 7.3.2. Commercial/Private Labs
- 7.3.3. Public Health Labs
7.4. PoC testing
- 7.4.1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by PoC testing, by Region, 2020-2034 (USD Billion)

8. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Molecular Diagnostics For Sexually Transmitted Diseases Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Molecular Diagnostics For Sexually Transmitted Diseases Market - North America
- 8.3.1. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
- 8.3.2. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.3.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - U.S.
  - 8.3.4.1. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.3.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Canada
  - 8.3.5.1. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
8.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Europe
- 8.4.1. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
- 8.4.2. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.4.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - UK
  - 8.4.4.1. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.4.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - France
  - 8.4.5.1. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.4.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Germany
  - 8.4.6.1. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.4.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Italy
  - 8.4.7.1. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.4.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Spain
  - 8.4.8.1. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.4.9. Molecular Diagnostics For Sexually Transmitted Diseases Market - Netherlands
  - 8.4.9.1. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.4.10. Molecular Diagnostics For Sexually Transmitted Diseases Market - Russia
  - 8.4.10.1. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.4.11. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
8.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Asia Pacific
- 8.5.1. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.5.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - China
  - 8.5.4.1. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.5.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - India
  - 8.5.5.1. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.5.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Malaysia
  - 8.5.6.1. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.5.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Japan
  - 8.5.7.1. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.5.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Indonesia
  - 8.5.8.1. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.5.9. Molecular Diagnostics For Sexually Transmitted Diseases Market - South Korea
  - 8.5.9.1. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.5.10. Molecular Diagnostics For Sexually Transmitted Diseases Market - Australia
  - 8.5.10.1. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.5.11. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
8.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.6.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.6.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - UAE
  - 8.6.5.1. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.6.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Israel
  - 8.6.6.1. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.6.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - South Africa
  - 8.6.7.1. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.6.8. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
8.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Latin America
- 8.7.1. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.7.4. Molecular Diagnostics For Sexually Transmitted Diseases Market - Mexico
  - 8.7.4.1. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.7.5. Molecular Diagnostics For Sexually Transmitted Diseases Market - Brazil
  - 8.7.5.1. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.7.6. Molecular Diagnostics For Sexually Transmitted Diseases Market - Argentina
  - 8.7.6.1. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
- 8.7.7. Molecular Diagnostics For Sexually Transmitted Diseases Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Abbott Laboratories
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Becton, Dickinson and Company (BD)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. bioMerieux SA
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. DiaSorin S.p. A.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. F. Hoffmann-La Roche AG (Roche Diagnostics)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Hologic Inc.
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. QIAGEN N.V.
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. QuidelOrtho Corporation
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Seegene Inc.
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Siemens Healthineers AG
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Thermo Fisher Scientific Inc.
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development

簡介目錄圖表

List of Tables:

Table 1 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 2 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 3 Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 4 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 5 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 6 North America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 7 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 8 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 9 U.S.: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 10 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 11 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 12 Canada: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 13 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 14 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 15 Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 16 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 17 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 18 UK: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 19 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 20 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 21 France: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 22 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 23 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 24 Germany: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 25 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 26 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 27 Italy: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 28 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 29 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 30 Spain: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 31 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 32 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 33 Netherlands: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 34 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 35 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 36 Russia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 37 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 38 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 39 Rest of Europe: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 40 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 41 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 42 Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 43 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 44 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 45 China: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 46 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 47 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 48 India: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 49 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 50 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 51 Malaysia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 52 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 53 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 54 Japan: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 55 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 56 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 57 Indonesia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 58 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 59 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 60 South Korea: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 61 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 62 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 63 Australia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 64 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 65 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 66 Rest of Asia Pacific: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 67 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 68 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 69 Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 70 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 71 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 72 Saudi Arabia: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 73 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 74 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 75 UAE: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 76 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 77 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 78 Israel: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 79 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 80 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 81 South Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 82 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 85 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 86 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 87 Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 88 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 89 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 90 Mexico: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 91 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 92 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 93 Brazil: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 94 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 95 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 96 Argentina: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)
Table 97 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2020-2034 (USD Billion)
Table 98 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2020-2034 (USD Billion)
Table 99 Rest of Latin America: Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Product
Figure 7. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Product, 2024 & 2034 (USD Billion)
Figure 8. Market by Application
Figure 9. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Application, 2024 & 2034 (USD Billion)
Figure 10. Market by Technology
Figure 11. Global Molecular Diagnostics For Sexually Transmitted Diseases Market, by Technology, 2024 & 2034 (USD Billion)